Nu Skin Reports Q2 2026 Financial Results
Nu Skin Enterprises reported Q2 2026 results. Revenue was $320.1M and gross margin was 68.2% versus 68.8% in Q2 2025. Q3 revenue guidance is $310M to $340M with EPS $0 to $0.09. Full-year 2026 revenue is guided to $1.28B to $1.35B and adjusted EPS to $0.70 to $0.90, per company statements.
How this was made
The 30-second read
Why it matters
Traders can update models using the provided Q2 results and the revised Q3 and full-year 2026 revenue and adjusted EPS ranges, then reassess risk around execution of Prysm iO and India expansion.
Market read
This is a guidance-and-results update with specific revenue and adjusted EPS ranges that can move near-term expectations and positioning.
What to watch
The article does not disclose cash flow, operating margin, or detailed segment performance, which can be the real drivers of estimate revisions despite revenue and gross margin stability.
Background
Nu Skin is progressing its long-term strategy via Prysm iO rollout and preparations for a formal India launch, while reallocating organizational resources.
Ticker impact
Nu Skin reported Q2 2026 revenue of $320.1M, stable gross margin near 68.2%, and updated full-year guidance to $1.28B-$1.35B.
Likely modest volatility around earnings/guidance expectations, with direction dependent on how the updated EPS range compares to Street consensus.
The article provides concrete quarterly results plus updated revenue and adjusted EPS ranges for Q3 and full-year 2026, which are direct inputs to valuation models and near-term positioning.
Market effects
Direct-selling peers may see read-across on demand durability and margin stability, but the article is company-specific.
India launch preparations could be a sentiment factor for emerging-market growth narratives in direct selling, without quantified impact here.
Limited broader market relevance beyond direct-selling and consumer discretionary growth expectations.
Counterpoint
Stable gross margin and midpoint EPS delivery may already be priced in; the guidance ranges could be viewed as incremental rather than a step-change.
Key entities
- companyNu Skin Enterprises Inc.
Reported Q2 2026 financial results and updated Q3 and full-year 2026 guidance.
- executiveRyan Napierski
CEO statement on Prysm iO rollout progress and preparations for India launch.
- executiveChelsea Lantz
Interim CFO statement on adjusted EPS delivery and guidance update.
